Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Clinical Pharmacology
|
January 18, 2013
Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease
Paul Matthias Diderichsen, Eugène Cox, Steven W Martin, et al.
Journal of Clinical Pharmacology
|
May 22, 2025
Population Pharmacokinetics and Exposure-Response Relationships of Etrolizumab in Patients with Moderately-to-Severely Active Crohn's Disease
Anita Moein, Jakob Ribbing, Moustafa M A Ibrahim, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 25, 2012
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease
Jace C Nielsen, Matthew M Hutmacher, Adriaan Cleton, et al.
European Journal of Clinical Pharmacology
|
March 3, 2012
Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second
Xipei Wang, Dewei Shang, Jakob Ribbing, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 5, 2022
Exposure-response relationships of etrolizumab in patients with moderately-to-severely active ulcerative colitis
Nastya Kassir, Rui Zhu, Anita Moein, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 19, 2022
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis
Anita Moein, Tong Lu, Siv Jönsson, et al.
Journal of Clinical Pharmacology
|
December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma
Naoki Kotani, Michael Dolton, Robin J Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 4, 2021
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires
Robin J Svensson, Jakob Ribbing, Naoki Kotani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 3, 2024
Covariate modeling in pharmacometrics: General points for consideration
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Clinical Pharmacology
|
January 18, 2013
Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease
Paul Matthias Diderichsen, Eugène Cox, Steven W Martin, et al.
Journal of Clinical Pharmacology
|
May 22, 2025
Population Pharmacokinetics and Exposure-Response Relationships of Etrolizumab in Patients with Moderately-to-Severely Active Crohn's Disease
Anita Moein, Jakob Ribbing, Moustafa M A Ibrahim, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 25, 2012
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease
Jace C Nielsen, Matthew M Hutmacher, Adriaan Cleton, et al.
European Journal of Clinical Pharmacology
|
March 3, 2012
Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second
Xipei Wang, Dewei Shang, Jakob Ribbing, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 5, 2022
Exposure-response relationships of etrolizumab in patients with moderately-to-severely active ulcerative colitis
Nastya Kassir, Rui Zhu, Anita Moein, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 19, 2022
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis
Anita Moein, Tong Lu, Siv Jönsson, et al.
Journal of Clinical Pharmacology
|
December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma
Naoki Kotani, Michael Dolton, Robin J Svensson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 4, 2021
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires
Robin J Svensson, Jakob Ribbing, Naoki Kotani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 3, 2024
Covariate modeling in pharmacometrics: General points for consideration
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, et al.
Page
of 2